Quotient Sciences
Quotient Sciences is seeking a Business Development Director to drive growth within its Clinical Pharmacology business, focusing on biologics and early-phase clinical development. The role involves generating new business, building strategic partnerships with biotech and pharmaceutical companies, and collaborating with internal scientific and operational teams to deliver tailored client solutions.
Headquarters
Nottingham, England, United Kingdom
Company Size
1001-5000 employees
Founded
1990
Quotient Sciences is a global contract research, development and manufacturing organization (CRDMO) that accelerates drug development from candidate selection through commercial launch. They provide integrated services for small molecule drugs and novel therapies, including Phase 1 clinical trials, formulation development, and drug manufacturing. Science-led insight and an end-to-end platform enable faster translation of molecules to patients, supporting sponsors with clinical research, development, and commercial-scale supply.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Quotient Sciences.
Quotient Sciences didn’t post a salary, so this is our estimate from similar listings.
30% below the average for this role
Executive Director, Business Development - EMEA
ICON plc
Medical Director, Early Clinical Development London ( hybrid role 2 days per week onsite)
biomarin
Director Clinical Pharmacology
Acadia Pharmaceuticals Inc.
Senior Director, Clinical Pharmacology
Vertex
Senior Director Business Development - Biologics (Europe)
lifelancer
Project Manager - Phase I, Early Development
lifelancer